Company news

InspireMD Inc. news in 2023

InspireMD Inc.'s news releases, calls and decks from 2023, newest first.

View company

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

December 19, 2023

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

November 26, 2023

InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update

November 5, 2023

InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23

October 31, 2023

InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid Stenting (CAS) to Include Both Asymptomatic and Standard Risk Patients

October 11, 2023

InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives

October 2, 2023

InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23

August 30, 2023

InspireMD Reports Second Quarter 2023 Financial Results and Provides Business Update

August 7, 2023

InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th

July 24, 2023

InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

June 25, 2023

InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

May 17, 2023

InspireMD Reports First Quarter 2023 Financial Results and Provides Business Update

May 15, 2023

InspireMD Announces Private Placement of Up to $113.6 Million

May 14, 2023

InspireMD Announces May 16, 2023 as New Date for First Quarter 2023 Results Conference Call and Webcast

May 11, 2023

InspireMD Announces May 15th as New Date for First Quarter 2023 Financial Results and Corporate Business Update

May 4, 2023

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform

April 30, 2023

InspireMD to Report First Quarter 2023 Financial Results on May 9, 2023, and Provide Corporate Business Update

April 26, 2023

InspireMD Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

March 29, 2023

InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

March 19, 2023

InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business Update

March 1, 2023

InspireMD Announces Hiring of Medical Device Commercial Veteran Shane Gleason as General Manager of North America and VP of Global Marketing

February 13, 2023

Calls in 2023

Decks in 2023